Novel drug shows efficacy in hepatic insufficiency

A novel drug comprising eight different amino acids showed efficacy in improvement of neurocognitive function, metabolism and other positive outcomes in patients with mild and moderate hepatic insufficiency, according to a press release issued by the manufacturer, Axcella.The company said the drug, AXA1665, was safe and well-tolerated by patients.“We believe the data from the AXA1665-002 study show AXA1665’s potential to address multiple fundamental dysregulations associated with cirrhosis and hepatic encephalopathy,” Manu Chakravarthy, MD, PhD, chief medical officer ofRead More

Share on facebook
Share on twitter
Share on linkedin